市場調査レポート
商品コード
1109475

粘液除去装置の世界市場(2022年~2026年)

Global Mucus Clearance Devices Market 2022-2026

出版日: | 発行: TechNavio | ページ情報: 英文 120 Pages | 納期: 即納可能 即納可能とは

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
粘液除去装置の世界市場(2022年~2026年)
出版日: 2022年07月27日
発行: TechNavio
ページ情報: 英文 120 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の粘液除去装置の市場規模は、2022年から2026年の予測期間に6.22%のCAGRで拡大し、1億9,328万米ドルの成長が予測されています。同市場を牽引する要因には、患者の意識の高まり、慢性肺疾患の罹患率の増加、喫煙人口の増加などが挙げられます。

当レポートでは、粘液除去装置の世界市場を調査し、市場規模や予測、市場の促進要因および課題、市場動向、地域別の市場分析、ベンダー情勢、主要ベンダー分析などの体系的な情報を提供しています。

目次

第1章 エグゼクティブサマリー

  • 市場概要

第2章 市場情勢

  • 市場エコシステム

第3章 市場規模

  • 市場の定義
  • 市場セグメント分析
  • 市場規模:2021年
  • 市場の見通し:2021年~2026年の予測

第4章 ファイブフォース分析

  • ファイブフォースのまとめ
  • 買い手の交渉力
  • 供給企業の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競合の脅威
  • 市況

第5章 エンドユーザー別の市場セグメンテーション

  • 市場内訳
  • エンドユーザー別比較
  • COPDと喘息
  • 嚢胞性線維症
  • その他
  • エンドユーザー別の市場機会

第6章 顧客情勢

  • 顧客情勢の概要

第7章 地域別情勢

  • 地域別セグメンテーション
  • 地域別比較
  • 北米
  • 欧州
  • アジア
  • その他の地域(ROW)
  • 米国
  • 中国
  • 英国
  • ドイツ
  • フランス
  • 地域別情勢の市場機会

第8章 促進要因、課題、動向

  • 市場促進要因
  • 市場の課題
  • 促進要因と課題の影響
  • 市場動向

第9章 ベンダー情勢

  • 概要
  • ベンダー情勢
  • ディスラプションの情勢
  • 業界のリスク

第10章 ベンダー分析

  • 対象ベンダー
  • ベンダーの市場ポジショニング
  • AbbVie Inc.
  • Electromed Inc.
  • HILL ROM HOLDINGS Inc.
  • Koninklijke Philips NV
  • Medical Acoustics Music
  • Monaghan Medical Corp.
  • PARI Medical Holding GmbH
  • Smiths Group Plc
  • Thayer Medical Corp.
  • VORTRAN Medical Technology Inc.

第11章 付録

  • 調査範囲
  • 包含と除外のチェックリスト
  • 米国ドルの通貨換算レート
  • 調査手法
  • 略語一覧

掲載物

  • 図表1:エグゼクティブサマリー-市場概要のチャート
  • 図表2:エグゼクティブサマリー-市場概要のデータテーブル
  • 図表3:エグゼクティブサマリー-世界市場の特徴に関するチャート
  • 図表4:エグゼクティブサマリー-地域別情勢市場のチャート
  • 図表5:エグゼクティブサマリー-エンドユーザー別の市場セグメンテーションのチャート
  • その他
図表

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by End-user
  • Exhibits6: Executive Summary - Chart on Incremental Growth
  • Exhibits7: Executive Summary - Data Table on Incremental Growth
  • Exhibits8: Executive Summary - Chart on Vendor Market Positioning
  • Exhibits9: Parent market
  • Exhibits10: Market Characteristics
  • Exhibits11: Offerings of vendors included in the market definition
  • Exhibits12: Market segments
  • Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibits17: Five forces analysis - Comparison between 2021 and 2026
  • Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
  • Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
  • Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
  • Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
  • Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
  • Exhibits23: Chart on Market condition - Five forces 2021 and 2026
  • Exhibits24: Chart on End-user - Market share 2021-2026 (%)
  • Exhibits25: Data Table on End-user - Market share 2021-2026 (%)
  • Exhibits26: Chart on Comparison by End-user
  • Exhibits27: Data Table on Comparison by End-user
  • Exhibits28: Chart on COPD and Asthma - Market size and forecast 2021-2026 ($ million)
  • Exhibits29: Data Table on COPD and Asthma - Market size and forecast 2021-2026 ($ million)
  • Exhibits30: Chart on COPD and Asthma - Year-over-year growth 2021-2026 (%)
  • Exhibits31: Data Table on COPD and Asthma - Year-over-year growth 2021-2026 (%)
  • Exhibits32: Chart on Cystic fibrosis - Market size and forecast 2021-2026 ($ million)
  • Exhibits33: Data Table on Cystic fibrosis - Market size and forecast 2021-2026 ($ million)
  • Exhibits34: Chart on Cystic fibrosis - Year-over-year growth 2021-2026 (%)
  • Exhibits35: Data Table on Cystic fibrosis - Year-over-year growth 2021-2026 (%)
  • Exhibits36: Chart on Other - Market size and forecast 2021-2026 ($ million)
  • Exhibits37: Data Table on Other - Market size and forecast 2021-2026 ($ million)
  • Exhibits38: Chart on Other - Year-over-year growth 2021-2026 (%)
  • Exhibits39: Data Table on Other - Year-over-year growth 2021-2026 (%)
  • Exhibits40: Market opportunity by End-user ($ million)
  • Exhibits41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits42: Chart on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibits43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibits44: Chart on Geographic comparison
  • Exhibits45: Data Table on Geographic comparison
  • Exhibits46: Chart on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibits47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibits48: Chart on North America - Year-over-year growth 2021-2026 (%)
  • Exhibits49: Data Table on North America - Year-over-year growth 2021-2026 (%)
  • Exhibits50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibits51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibits52: Chart on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibits53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibits54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibits55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibits56: Chart on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibits57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibits58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibits59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibits60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibits61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibits62: Chart on US - Market size and forecast 2021-2026 ($ million)
  • Exhibits63: Data Table on US - Market size and forecast 2021-2026 ($ million)
  • Exhibits64: Chart on US - Year-over-year growth 2021-2026 (%)
  • Exhibits65: Data Table on US - Year-over-year growth 2021-2026 (%)
  • Exhibits66: Chart on China - Market size and forecast 2021-2026 ($ million)
  • Exhibits67: Data Table on China - Market size and forecast 2021-2026 ($ million)
  • Exhibits68: Chart on China - Year-over-year growth 2021-2026 (%)
  • Exhibits69: Data Table on China - Year-over-year growth 2021-2026 (%)
  • Exhibits70: Chart on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibits71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibits72: Chart on UK - Year-over-year growth 2021-2026 (%)
  • Exhibits73: Data Table on UK - Year-over-year growth 2021-2026 (%)
  • Exhibits74: Chart on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibits75: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibits76: Chart on Germany - Year-over-year growth 2021-2026 (%)
  • Exhibits77: Data Table on Germany - Year-over-year growth 2021-2026 (%)
  • Exhibits78: Chart on France - Market size and forecast 2021-2026 ($ million)
  • Exhibits79: Data Table on France - Market size and forecast 2021-2026 ($ million)
  • Exhibits80: Chart on France - Year-over-year growth 2021-2026 (%)
  • Exhibits81: Data Table on France - Year-over-year growth 2021-2026 (%)
  • Exhibits82: Market opportunity By Geographical Landscape ($ million)
  • Exhibits83: Impact of drivers and challenges in 2021 and 2026
  • Exhibits84: Overview on Criticality of inputs and Factors of differentiation
  • Exhibits85: Overview on factors of disruption
  • Exhibits86: Impact of key risks on business
  • Exhibits87: Vendors covered
  • Exhibits88: Matrix on vendor position and classification
  • Exhibits89: AbbVie Inc. - Overview
  • Exhibits90: AbbVie Inc. - Product / Service
  • Exhibits91: AbbVie Inc. - Key offerings
  • Exhibits92: Electromed Inc. - Overview
  • Exhibits93: Electromed Inc. - Business segments
  • Exhibits94: Electromed Inc. - Key offerings
  • Exhibits95: Electromed Inc. - Segment focus
  • Exhibits96: HILL ROM HOLDINGS Inc. - Overview
  • Exhibits97: HILL ROM HOLDINGS Inc. - Business segments
  • Exhibits98: HILL ROM HOLDINGS Inc. - Key news
  • Exhibits99: HILL ROM HOLDINGS Inc. - Key offerings
  • Exhibits100: HILL ROM HOLDINGS Inc. - Segment focus
  • Exhibits101: Koninklijke Philips NV - Overview
  • Exhibits102: Koninklijke Philips NV - Business segments
  • Exhibits103: Koninklijke Philips NV - Key news
  • Exhibits104: Koninklijke Philips NV - Key offerings
  • Exhibits105: Koninklijke Philips NV - Segment focus
  • Exhibits106: Medical Acoustics Music - Overview
  • Exhibits107: Medical Acoustics Music - Product / Service
  • Exhibits108: Medical Acoustics Music - Key offerings
  • Exhibits109: Monaghan Medical Corp. - Overview
  • Exhibits110: Monaghan Medical Corp. - Product / Service
  • Exhibits111: Monaghan Medical Corp. - Key offerings
  • Exhibits112: PARI Medical Holding GmbH - Overview
  • Exhibits113: PARI Medical Holding GmbH - Product / Service
  • Exhibits114: PARI Medical Holding GmbH - Key offerings
  • Exhibits115: Smiths Group Plc - Overview
  • Exhibits116: Smiths Group Plc - Business segments
  • Exhibits117: Smiths Group Plc - Key news
  • Exhibits118: Smiths Group Plc - Key offerings
  • Exhibits119: Smiths Group Plc - Segment focus
  • Exhibits120: Thayer Medical Corp. - Overview
  • Exhibits121: Thayer Medical Corp. - Product / Service
  • Exhibits122: Thayer Medical Corp. - Key offerings
  • Exhibits123: VORTRAN Medical Technology Inc. - Overview
  • Exhibits124: VORTRAN Medical Technology Inc. - Product / Service
  • Exhibits125: VORTRAN Medical Technology Inc. - Key offerings
  • Exhibits126: Inclusions checklist
  • Exhibits127: Exclusions checklist
  • Exhibits128: Currency conversion rates for US$
  • Exhibits129: Research methodology
  • Exhibits130: Validation techniques employed for market sizing
  • Exhibits131: Information sources
  • Exhibits132: List of abbreviations
目次
Product Code: IRTNTR74015

Technavio has been monitoring the mucus clearance devices market and it is poised to grow by $ 193.28 mn during 2022-2026, accelerating at a CAGR of 6.22% during the forecast period. Our report on the mucus clearance devices market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by an increase in patient awareness, a growing incidence of chronic pulmonary disease, and subsequent growth in the smoking population.

The mucus clearance devices market analysis includes the end-user segment and geographic landscape.

Technavio's mucus clearance devices market is segmented as below:

By End-user

  • COPD and asthma
  • cystic fibrosis
  • other

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the impact of Covid-19 as one of the prime reasons driving the mucus clearance devices market growth during the next few years. Also, a supportive regulatory environment for the development and sale of mucus clearance devices and a rising number of specialized clinics, rehabilitation centers, ambulatory surgical centers, and hospitals will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the mucus clearance devices market covers the following areas:

  • Mucus clearance devices market sizing
  • Mucus clearance devices market forecast
  • Mucus clearance devices market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading mucus clearance devices market vendors that include AbbVie Inc., CEGLA Medizintechnik GmbH and Co. KG, D R BURTON HEALTHCARE LLC, Electromed Inc., General Physiotherapy Inc., HILL ROM HOLDINGS Inc., Informa Plc, Koninklijke Philips NV, Medical Acoustics Music, Monaghan Medical Corp., PARI Medical Holding GmbH, Smiths Group Plc, Thayer Medical Corp., and VORTRAN Medical Technology Inc. Also, the mucus clearance devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
  • Exhibit 01: Executive Summary - Chart on Market Overview
  • Exhibit 02: Executive Summary - Data Table on Market Overview
  • Exhibit 03: Executive Summary - Chart on Global Market Characteristics
  • Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user
  • Exhibit 06: Executive Summary - Chart on Incremental Growth
  • Exhibit 07: Executive Summary - Data Table on Incremental Growth
  • Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
  • Exhibit 09: Parent market
  • Exhibit 10: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
  • Exhibit 11: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
  • Exhibit 12: Market segments
  • 3.3 Market size 2021
  • 3.4 Market outlook: Forecast for 2021-2026
  • Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

  • 4.1 Five forces summary
  • Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
  • 4.2 Bargaining power of buyers
  • Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
  • 4.3 Bargaining power of suppliers
  • Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
  • 4.4 Threat of new entrants
  • Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
  • 4.5 Threat of substitutes
  • Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
  • 4.6 Threat of rivalry
  • Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
  • 4.7 Market condition
  • Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by End-user

  • 5.1 Market segments
  • Exhibit 24: Chart on End-user - Market share 2021-2026 (%)
  • Exhibit 25: Data Table on End-user - Market share 2021-2026 (%)
  • 5.2 Comparison by End-user
  • Exhibit 26: Chart on Comparison by End-user
  • Exhibit 27: Data Table on Comparison by End-user
  • 5.3 COPD and Asthma - Market size and forecast 2021-2026
  • Exhibit 28: Chart on COPD and Asthma - Market size and forecast 2021-2026 ($ million)
  • Exhibit 29: Data Table on COPD and Asthma - Market size and forecast 2021-2026 ($ million)
  • Exhibit 30: Chart on COPD and Asthma - Year-over-year growth 2021-2026 (%)
  • Exhibit 31: Data Table on COPD and Asthma - Year-over-year growth 2021-2026 (%)
  • 5.4 Cystic fibrosis - Market size and forecast 2021-2026
  • Exhibit 32: Chart on Cystic fibrosis - Market size and forecast 2021-2026 ($ million)
  • Exhibit 33: Data Table on Cystic fibrosis - Market size and forecast 2021-2026 ($ million)
  • Exhibit 34: Chart on Cystic fibrosis - Year-over-year growth 2021-2026 (%)
  • Exhibit 35: Data Table on Cystic fibrosis - Year-over-year growth 2021-2026 (%)
  • 5.5 Other - Market size and forecast 2021-2026
  • Exhibit 36: Chart on Other - Market size and forecast 2021-2026 ($ million)
  • Exhibit 37: Data Table on Other - Market size and forecast 2021-2026 ($ million)
  • Exhibit 38: Chart on Other - Year-over-year growth 2021-2026 (%)
  • Exhibit 39: Data Table on Other - Year-over-year growth 2021-2026 (%)
  • 5.6 Market opportunity by End-user
  • Exhibit 40: Market opportunity by End-user ($ million)

6 Customer Landscape

  • 6.1 Customer landscape overview
  • Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

  • 7.1 Geographic segmentation
  • Exhibit 42: Chart on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibit 43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
  • 7.2 Geographic comparison
  • Exhibit 44: Chart on Geographic comparison
  • Exhibit 45: Data Table on Geographic comparison
  • 7.3 North America - Market size and forecast 2021-2026
  • Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
  • Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
  • 7.4 Europe - Market size and forecast 2021-2026
  • Exhibit 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibit 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibit 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibit 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
  • 7.5 Asia - Market size and forecast 2021-2026
  • Exhibit 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibit 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibit 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibit 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
  • 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
  • Exhibit 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibit 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibit 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibit 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • 7.7 US - Market size and forecast 2021-2026
  • Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
  • Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
  • Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
  • Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)
  • 7.8 China - Market size and forecast 2021-2026
  • Exhibit 66: Chart on China - Market size and forecast 2021-2026 ($ million)
  • Exhibit 67: Data Table on China - Market size and forecast 2021-2026 ($ million)
  • Exhibit 68: Chart on China - Year-over-year growth 2021-2026 (%)
  • Exhibit 69: Data Table on China - Year-over-year growth 2021-2026 (%)
  • 7.9 UK - Market size and forecast 2021-2026
  • Exhibit 70: Chart on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibit 71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibit 72: Chart on UK - Year-over-year growth 2021-2026 (%)
  • Exhibit 73: Data Table on UK - Year-over-year growth 2021-2026 (%)
  • 7.10 Germany - Market size and forecast 2021-2026
  • Exhibit 74: Chart on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibit 75: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibit 76: Chart on Germany - Year-over-year growth 2021-2026 (%)
  • Exhibit 77: Data Table on Germany - Year-over-year growth 2021-2026 (%)
  • 7.11 France - Market size and forecast 2021-2026
  • Exhibit 78: Chart on France - Market size and forecast 2021-2026 ($ million)
  • Exhibit 79: Data Table on France - Market size and forecast 2021-2026 ($ million)
  • Exhibit 80: Chart on France - Year-over-year growth 2021-2026 (%)
  • Exhibit 81: Data Table on France - Year-over-year growth 2021-2026 (%)
  • 7.12 Market opportunity By Geographical Landscape
  • Exhibit 82: Market opportunity By Geographical Landscape ($ million)

8 Drivers, Challenges, and Trends

  • 8.1 Market drivers
  • 8.2 Market challenges
  • 8.3 Impact of drivers and challenges
  • Exhibit 83: Impact of drivers and challenges in 2021 and 2026
  • 8.4 Market trends

9 Vendor Landscape

  • 9.1 Overview
  • 9.2 Vendor landscape
  • Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
  • 9.3 Landscape disruption
  • Exhibit 85: Overview on factors of disruption
  • 9.4 Industry risks
  • Exhibit 86: Impact of key risks on business

10 Vendor Analysis

  • 10.1 Vendors covered
  • Exhibit 87: Vendors covered
  • 10.2 Market positioning of vendors
  • Exhibit 88: Matrix on vendor position and classification
  • 10.3 AbbVie Inc.
  • Exhibit 89: AbbVie Inc. - Overview
  • Exhibit 90: AbbVie Inc. - Product / Service
  • Exhibit 91: AbbVie Inc. - Key offerings
  • 10.4 Electromed Inc.
  • Exhibit 92: Electromed Inc. - Overview
  • Exhibit 93: Electromed Inc. - Business segments
  • Exhibit 94: Electromed Inc. - Key offerings
  • Exhibit 95: Electromed Inc. - Segment focus
  • 10.5 HILL ROM HOLDINGS Inc.
  • Exhibit 96: HILL ROM HOLDINGS Inc. - Overview
  • Exhibit 97: HILL ROM HOLDINGS Inc. - Business segments
  • Exhibit 98: HILL ROM HOLDINGS Inc. - Key news
  • Exhibit 99: HILL ROM HOLDINGS Inc. - Key offerings
  • Exhibit 100: HILL ROM HOLDINGS Inc. - Segment focus
  • 10.6 Koninklijke Philips NV
  • Exhibit 101: Koninklijke Philips NV - Overview
  • Exhibit 102: Koninklijke Philips NV - Business segments
  • Exhibit 103: Koninklijke Philips NV - Key news
  • Exhibit 104: Koninklijke Philips NV - Key offerings
  • Exhibit 105: Koninklijke Philips NV - Segment focus
  • 10.7 Medical Acoustics Music
  • Exhibit 106: Medical Acoustics Music - Overview
  • Exhibit 107: Medical Acoustics Music - Product / Service
  • Exhibit 108: Medical Acoustics Music - Key offerings
  • 10.8 Monaghan Medical Corp.
  • Exhibit 109: Monaghan Medical Corp. - Overview
  • Exhibit 110: Monaghan Medical Corp. - Product / Service
  • Exhibit 111: Monaghan Medical Corp. - Key offerings
  • 10.9 PARI Medical Holding GmbH
  • Exhibit 112: PARI Medical Holding GmbH - Overview
  • Exhibit 113: PARI Medical Holding GmbH - Product / Service
  • Exhibit 114: PARI Medical Holding GmbH - Key offerings
  • 10.10 Smiths Group Plc
  • Exhibit 115: Smiths Group Plc - Overview
  • Exhibit 116: Smiths Group Plc - Business segments
  • Exhibit 117: Smiths Group Plc - Key news
  • Exhibit 118: Smiths Group Plc - Key offerings
  • Exhibit 119: Smiths Group Plc - Segment focus
  • 10.11 Thayer Medical Corp.
  • Exhibit 120: Thayer Medical Corp. - Overview
  • Exhibit 121: Thayer Medical Corp. - Product / Service
  • Exhibit 122: Thayer Medical Corp. - Key offerings
  • 10.12 VORTRAN Medical Technology Inc.
  • Exhibit 123: VORTRAN Medical Technology Inc. - Overview
  • Exhibit 124: VORTRAN Medical Technology Inc. - Product / Service
  • Exhibit 125: VORTRAN Medical Technology Inc. - Key offerings

11 Appendix

  • 11.1 Scope of the report
  • 11.2 Inclusions and exclusions checklist
  • Exhibit 126: Inclusions checklist
  • Exhibit 127: Exclusions checklist
  • 11.3 Currency conversion rates for US$
  • Exhibit 128: Currency conversion rates for US$
  • 11.4 Research methodology
  • Exhibit 129: Research methodology
  • Exhibit 130: Validation techniques employed for market sizing
  • Exhibit 131: Information sources
  • 11.5 List of abbreviations
  • Exhibit 132: List of abbreviations